Patient information concerning the benefits and related uncertainties of anticancer drugs in Europe is absent or inadequate, according to a study.
[News] EU cancer drug leaflets contain insufficient information
For Additional News from OncWeekly – Your Front Row Seat To The Future of Cancer Care –
LATEST
Sign up for our emails
Trusted insights straight to your inbox and get the latest updates from OncWeekly
Newsletter
Privacy Policy